KIDRON NADAV — SEC Form 4 filings
SEC reporting owner CIK 1351779. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-25.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-11-08 to 2026-08-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | President and CEO, Director | 8 | — | — | 13 |
| Nano Dimension Ltd. (NNDM) | Director | 1 | — | — | 2 |
| Lifeward Ltd. (LFWD) | Director | 1 | — | — | 1 |
Form 4 filings — KIDRON NADAV
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-25 | 4 | Nano Dimension Ltd. (NNDM) | Option exercise/expiry (X): 10,000 @ $1.50 · Option exercise/expiry (X): 100 (derivative) @ $0 | EDGAR |
| 2026-03-31 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Tax withholding (F): 44,818 @ $3.31 | EDGAR |
| 2026-03-27 | 4 | Lifeward Ltd. (LFWD) | Grant/award (A): 7,657 @ $0 | EDGAR |
| 2026-03-18 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 167,005 @ $0 | EDGAR |
| 2026-03-16 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Gift (G): 100,000 @ $0 | EDGAR |
| 2026-01-29 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Option exercise (M): 109,000 @ $0 · Option exercise (M): 109,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 232,640 @ $0 · Grant/award (A): 327,000 @ $0 · Grant/award (A): 109,000 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 141,000 @ $0 · Grant/award (A): 186,000 @ $0 · Grant/award (A): 100,000 @ $0 | EDGAR |
| 2025-01-06 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 433,500 | EDGAR |
| 2024-11-08 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 45,000 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1351779 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →